Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Mumbai (Maharashtra) [India], March 21: Airports can feel easy right up until the immigration counter,…
An unforgettable evening in Mumbai honours the visionaries transforming India’s culinary and lifestyle landscapeThe fourth…
Kolkata (West Bengal) [India], March 24: BTL EPC Ltd has secured a prestigious ₹590 crore order…
MATTER Showcases AI-Driven Motorcycles as Mohal Lalbhai Talks Future of Mobility. New Delhi, 20 March…
The Leela Annual Golf Tournament 2026 – 4th Edition, Celebrating Community, Commitment, and the Future…
Shivam Jewels selected as DTC sightholder, expected to give fresh impetus to the diamond industry.…